GSA CAPITAL PARTNERS LLP

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in PLRX

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$506,635

-$254,276 QoQ

Shares Held

402,092

-35.5% QoQ

Ownership

0.649%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $101,563,069 across 163 Biotechnology names. PLRX ranks #70 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	3,831	$2,959,983
2	ARDX	Ardelyx, Inc.	473,061	$2,833,635
3	NTLA	Intellia Therapeutics, Inc.	178,301	$2,285,818
4	NUVB	Nuvation Bio Inc.	495,792	$2,126,947
5	RXRX	Recursion Pharmaceuticals, Inc.	669,568	$2,055,573
6	WVE	Wave Life Sciences Ltd.	282,719	$2,049,712
7	SRPT	Sarepta Therapeutics, Inc.	90,960	$1,979,289
8	IOVA	Iovance Biotherapeutics, Inc.	557,085	$1,955,368

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$506,635	402,092	-35.5%	Shares	Sole	2026-05-08
2025-12-31	$760,911	623,698	+287.7%	Shares	Sole	2026-02-06
2025-09-30	$238,108	160,884	+1037.6%	Shares	Sole	2025-11-07
2025-06-30	$16,404	14,142	-59.2%	Shares	Sole	2025-07-22
2025-03-31	$46,807	34,672	-23.9%	Shares	Sole	2025-05-08
2023-09-30	$790,478	45,587	+137.4%	Shares	Sole	2023-11-15
2023-03-31	$510,879	19,206	-5.2%	Shares	Sole	2023-05-12
2022-12-31	$391,606	20,259	-8.9%	Shares	Sole	2023-02-13
2022-09-30	$464,489	22,235	-69.6%	Shares	Sole	2022-11-14
2022-06-30	$585,154	73,053	+7.1%	Shares	Sole	2022-08-09
2022-03-31	$478,334	68,236	+16.5%	Shares	Sole	2022-05-11
2021-12-31	$791,005	58,593	+126.5%	Shares	Sole	2022-02-14
2021-09-30	$436,634	25,867	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.